BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20979234)

  • 1. Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10.
    Frank-Raue K; Rybicki LA; Erlic Z; Schweizer H; Winter A; Milos I; Toledo SP; Toledo RA; Tavares MR; Alevizaki M; Mian C; Siggelkow H; Hüfner M; Wohllk N; Opocher G; Dvořáková S; Bendlova B; Czetwertynska M; Skasko E; Barontini M; Sanso G; Vorländer C; Maia AL; Patocs A; Links TP; de Groot JW; Kerstens MN; Valk GD; Miehle K; Musholt TJ; Biarnes J; Damjanovic S; Muresan M; Wüster C; Fassnacht M; Peczkowska M; Fauth C; Golcher H; Walter MA; Pichl J; Raue F; Eng C; Neumann HP;
    Hum Mutat; 2011 Jan; 32(1):51-8. PubMed ID: 20979234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
    Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP
    Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation.
    Mian C; Barollo S; Zambonin L; Pennelli G; Bernante P; Pelizzo MR; Nacamulli D; Mantero F; Girelli ME; Opocher G
    Fam Cancer; 2009; 8(4):379-82. PubMed ID: 19475497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients.
    Imai T; Uchino S; Okamoto T; Suzuki S; Kosugi S; Kikumori T; Sakurai A;
    Eur J Endocrinol; 2013 May; 168(5):683-7. PubMed ID: 23416954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon-specific penetrance and changes in management during the last four decades.
    Mucha L; Leidig-Bruckner G; Frank-Raue K; Bruckner T; Kroiss M; Raue F;
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):320-326. PubMed ID: 28605116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
    Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
    Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
    Castro MR; Thomas BC; Richards ML; Zhang J; Morris JC
    Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RET codon 609 mutations: a contribution for better clinical managing.
    Mian C; Sartorato P; Barollo S; Zane M; Opocher G
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):33-6. PubMed ID: 22584703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
    Moers AM; Landsvater RM; Schaap C; Jansen-Schillhorn van Veen JM; de Valk IA; Blijham GH; Höppener JW; Vroom TM; van Amstel HK; Lips CJ
    Am J Med; 1996 Dec; 101(6):635-41. PubMed ID: 9003111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].
    Weng Y; Xue SN; Zhang SL; Cheng H; Yan L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):134-137. PubMed ID: 29397600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?
    Gimm O; Niederle BE; Weber T; Bockhorn M; Ukkat J; Brauckhoff M; Thanh PN; Frilling A; Klar E; Niederle B; Dralle H
    Surgery; 2002 Dec; 132(6):952-9; discussion 959. PubMed ID: 12490841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 6-Base Pair in Frame Germline Deletion in Exon 7 Of RET Leads to Increased RET Phosphorylation, ERK Activation, and MEN2A.
    Latteyer S; Klein-Hitpass L; Khandanpour C; Zwanziger D; Poeppel TD; Schmid KW; Führer D; Moeller LC
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1016-22. PubMed ID: 26765577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation.
    González-Yebra B; Medrano ME; Mantilla A; Palma V; Colin C; Hernández DM; Tapia J; Dawson B; Salcedo M
    Endocr Pathol; 2003; 14(1):71-80. PubMed ID: 12746565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 2.
    Wohllk N; Schweizer H; Erlic Z; Schmid KW; Walz MK; Raue F; Neumann HP
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):371-87. PubMed ID: 20833330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype-phenotype correlation: an appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilian families.
    Valente FO; Dias da Silva MR; Camacho CP; Kunii IS; Bastos AU; da Fonseca CC; Simião HP; Tamanaha R; Maciel RM; Cerutti JM
    J Endocrinol Invest; 2013 Dec; 36(11):975-81. PubMed ID: 23723040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
    Zhou YL; Zhu SX; Li JJ; Liu JB; Yin M; Xiao BY; Yu CL; Wang LM; Gu LQ; Cui B; Ning G; Li XY; Zhao YJ
    Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RET codon 618 mutations in Saudi families with multiple endocrine neoplasia Type 2A and familial medullary thyroid carcinoma.
    Qari F
    Ann Saudi Med; 2013; 33(2):155-8. PubMed ID: 23563004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Homozygous RET K666N Genotype With an MEN2A Phenotype.
    Jaber T; Hyde SM; Cote GJ; Grubbs EG; Giles WH; Stevens CA; Dadu R
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1269-1272. PubMed ID: 29408964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2.
    Thosani S; Ayala-Ramirez M; Palmer L; Hu MI; Rich T; Gagel RF; Cote G; Waguespack SG; Habra MA; Jimenez C
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1813-9. PubMed ID: 24030942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.